SIR – Sherelle Jacobs (Comment, January 25) highlights the myopic defence decisions taken by successive British governments since the end of the Cold War.
The UK has opened the final consultation on its plans to revise the rules regulating clinical trials, the country’s latest post-Brexit act of scientific deregulation that has seen it take a more laissez-faire attitude in other areas like gene editing and artificial intelligence.
Gilead joins the Association of the British Pharmaceutical Industry europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.